Ipca Laboratories (IPCALAB) Share Price falls 2.17% as stock declines to Rs 1,953.40
- September 25, 2026
- Posted by: Harsh Piplani
- Category: News
Ipca Laboratories Share Price moved lower today, with the stock ending at Rs 1,953.40, down 2.17% from the previous close of Rs 1,996.65. The company’s market capitalisation is Rs 49,808.48 crore, which places it in the Large Cap category. In this Ipca Laboratories Share Price Today note, the verified numbers show a clear same-day decline, but the supplied data does not establish a company-specific catalyst. That makes the session relevant for readers looking at Ipca Laboratories Stock News, Ipca Laboratories Share News and Ipca Laboratories Share Price Fall in a factual, event-led way.
The stock opened at Rs 2,019.20 and also marked the day’s high at Rs 2,019.20 before slipping to a low of Rs 1,951.40. Turnover stood at Rs 1.54 crore. The move is therefore best read as a price action event first and foremost: current price, intraday range and the gap versus the previous close are all visible, while the reason for the decline is not supplied in the data. For Univest readers tracking Ipca Laboratories Share Price Live, the key question is how this session fits within its valuation and sector backdrop.
Ipca Laboratories (IPCALAB) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,953.4 |
| Previous Close | Rs 1,996.65 |
| Today's Move | -Rs 43.25 (-2.17%) |
| Open | Rs 2,019.2 |
| High | Rs 2,019.2 |
| Low | Rs 1,951.4 |
| Turnover | Rs 1.54 crore |
| Market Capitalisation | Rs 49,808.48 crore |
| Market Cap Category | Large Cap |
Ipca Laboratories Share Price Today closed at Rs 1,953.40 after a decline of Rs 43.25. The previous close was Rs 1,996.65, which means the stock moved down by 2.17% in the session. The day opened at Rs 2,019.20 and the same level became the intraday high, showing that the early session peak did not hold. The low for the day was Rs 1,951.40, so the stock finished very close to the day’s bottom.
That intraday path matters because it shows the full range of today’s move without adding an unsupported explanation. In simple terms, Ipca Laboratories Share Price moved from an opening level above the previous close to a lower finish by the end of the session. The turnover was Rs 1.54 crore, which is the exact traded value supplied for the day and should be read as a factual transaction value, not as a cause for the decline. With the market-cap category at Large Cap and market capitalisation at Rs 49,808.48 crore, the stock remains a sizeable healthcare name even on a weaker day. For readers following Ipca Laboratories Stock News and Ipca Laboratories Share Price Update, today’s action is notable because the decline came after an opening at the session high. That sets up the next question around valuation and financial context, which Univest covers below.
Ipca Laboratories (IPCALAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 49,808.48 crore |
| P/E Ratio | 38.67x |
| P/B Ratio | 5.97x |
| ROE | 15.88% |
| ROCE | 19.41% |
| EPS | Rs 51.63 |
| Book Value Per Share | Rs 334.38 |
| Dividend Yield | 0.3% |
Ipca Laboratories Share Price today sits alongside a market capitalisation of Rs 49,808.48 crore, an enterprise-value context that investors normally assess with profitability and valuation data. The company is trading at a P/E ratio of 38.67 and a P/B ratio of 5.97, while ROE stands at 15.88% and ROCE at 19.41%. EPS is Rs 51.63 and book value is Rs 334.38 per share. Dividend yield is 0.3%.
These figures give the session more context than price alone. The P/E ratio shows how the market is pricing current earnings, while the P/B ratio places the stock above book value. ROE and ROCE both remain positive and useful for understanding how profit and capital efficiency compare with other healthcare names. EPS of Rs 51.63 confirms earnings per share at a meaningful level, and book value of Rs 334.38 provides an accounting base for each share. Dividend yield at 0.3% is a small but explicit income metric. In an Ipca Laboratories Fundamental Analysis lens, today’s share price fall does not alter these reported figures, but it does bring valuation into focus. For readers scanning Ipca Laboratories Stock Analysis or Ipca Laboratories Latest News, the key takeaway is that the decline happened against a backdrop of established profitability metrics rather than any newly supplied adverse fundamental event.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 38.67x |
| Benchmark Median P/E | 32.73x |
| Benchmark Average P/E | 49.58x |
| Benchmark P/E Range | 3.48x to 757.76x |
| Company P/B Ratio | 5.97x |
| Benchmark Median P/B | 2.95x |
| Benchmark Average P/B | 4.37x |
| Company ROE | 15.88% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.7% |
| Company ROCE | 19.41% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 49,808.48 crore |
| Benchmark Median Market Cap | Rs 804.62 crore |
| Benchmark Average Market Cap | Rs 14,476.05 crore |
Ipca Laboratories operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Within the same industry benchmark, the company’s P/E ratio of 38.67 sits above the median of 32.73 but below the benchmark average of 49.58 across 169 companies with P/E data. Its P/B ratio of 5.97 is above the benchmark median of 2.95 and above the benchmark average of 4.37 across 198 companies. ROE at 15.88% is above the industry median of 11.7% and above the average of 10.7%, while ROCE at 19.41% is also above the median of 13.61% and the average of 13.4% across 199 companies.
The benchmark scope is the same industry, with 199 companies in the broader group for the profitability and market-cap comparisons. On market capitalisation, Ipca Laboratories at Rs 49,808.48 crore is well above the industry median of Rs 804.62 crore and also above the average of Rs 14,476.05 crore. That does not make the stock better or worse by itself; it simply places the company among larger names in its peer set. In this sector and industry context, Ipca Laboratories Share Price remains part of a broad healthcare universe where valuation dispersion is wide, and the company’s ratio profile should be read relative to the benchmark numbers rather than in isolation. For Univest readers, this is the right setting to interpret Ipca Laboratories Share Price News alongside the company’s fundamentals and peer comparisons.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,47,475.97 | 36.76 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,54,763.56 | 87.25 | 14.45 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,423.19 | 86.07 | 20.91 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,16,658.07 | 26.08 | 4.37 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,11,484.47 | 33.65 | 3.23 | 11.83 | 16 |
Among the supplied peers, Ipca Laboratories’ market capitalisation of Rs 49,808.48 crore is below Sun Pharmaceutical Industries at Rs 4,47,475.97 crore, Divi’s Laboratories at Rs 2,54,763.56 crore, Torrent Pharmaceuticals at Rs 1,89,423.19 crore, Zydus Lifesciences at Rs 1,16,658.07 crore and Cipla at Rs 1,11,484.47 crore. That places Ipca Laboratories in a smaller peer bracket within the listed healthcare group shown here.
On valuation, its P/E of 38.67 is above Zydus Lifesciences at 26.08, Cipla at 33.65 and Dr. Reddy’s Laboratories at 31.1 from the broader industry list, but below Divi’s Laboratories at 87.25, Torrent Pharmaceuticals at 86.07 and Laurus Labs at 100.13. Its P/B of 5.97 is higher than Zydus Lifesciences at 4.37, Cipla at 3.23 and Dr. Reddy’s Laboratories at 2.62, but below Divi’s Laboratories, Torrent Pharmaceuticals and Laurus Labs. ROE at 15.88% and ROCE at 19.41% sit in a balanced zone versus the peer set. In Ipca Laboratories Stock News terms, the peer picture shows a company with meaningful profitability metrics and a valuation that is neither the cheapest nor the most expensive among the names supplied.
Why Investors Are Watching Ipca Laboratories
- Ipca Laboratories Share Price fell 2.17% today to Rs 1,953.40 from Rs 1,996.65.
- The session opened and peaked at Rs 2,019.20 before the stock finished near the day’s low of Rs 1,951.40.
- Market capitalisation stands at Rs 49,808.48 crore and the company is classified as Large Cap.
- P/E is 38.67, P/B is 5.97, ROE is 15.88% and ROCE is 19.41%.
- In the same industry benchmark, the company’s P/E and P/B sit above the median, while ROE and ROCE are also above the median.
About Ipca Laboratories
Ipca Laboratories is part of the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies it within the listed pharmaceutical universe used for the industry benchmark and peer comparison. In today’s Ipca Laboratories Share Price context, the company is discussed mainly through its market capitalisation, valuation ratios and profitability metrics. Univest readers tracking Ipca Laboratories Company News or Ipca Laboratories Market Cap can use this factual frame to connect the day’s price move with the company’s broader listed profile. No extra business-line assumptions are added here beyond the sector and industry classification supplied in the dataset.
Track Ipca Laboratories Share Price on Univest
Use Ipca Laboratories (IPCALAB) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Ipca Laboratories Share Price on Univest for live price updates, share price news, valuation ratios, shareholding pattern, 52-week levels and market insights. Univest also presents company pages for Ipca Laboratories Stock News, Ipca Laboratories Share Price Today and Ipca Laboratories Stock Analysis in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Ipca Laboratories Share Price fall today?
Ans. Ipca Laboratories Share Price fell 2.17% to Rs 1,953.40 from Rs 1,996.65. The supplied data confirms the decline, but it does not establish a company-specific catalyst for today’s move. The previous close was Rs 1,996.65.
What is Ipca Laboratories Share Price today?
Ans. Ipca Laboratories Share Price today is Rs 1,953.40. The stock declined Rs 43.25 in the session, and the opening level of Rs 2,019.20 was also the day’s high. The previous close was Rs 1,996.65.
What is Ipca Laboratories market capitalisation?
Ans. Ipca Laboratories has a market capitalisation of Rs 49,808.48 crore. The company is classified as Large Cap in the supplied data, which helps place the stock in a broader listed-company context.
How does Ipca Laboratories look on valuation metrics?
Ans. Ipca Laboratories trades at a P/E of 38.67 and a P/B of 5.97. EPS is Rs 51.63, book value is Rs 334.38 and dividend yield is 0.3%, giving a detailed valuation picture.
How does Ipca Laboratories compare with the healthcare sector benchmark?
Ans. In the same industry benchmark, Ipca Laboratories’ P/E of 38.67 is above the median of 32.73, while ROE at 15.88% and ROCE at 19.41% are also above the benchmark medians.
What does today’s Ipca Laboratories Share Price action show?
Ans. Today’s Ipca Laboratories Share Price action shows a decline after an opening at Rs 2,019.20, a high at the same level and a low of Rs 1,951.40. It finished close to the low.
What are the key profitability metrics for Ipca Laboratories?
Ans. The key profitability metrics are ROE at 15.88% and ROCE at 19.41%. Together with EPS of Rs 51.63, they give investors a clearer picture of the company’s reported financial profile.
How can investors track Ipca Laboratories Share Price on Univest?
Ans. Investors can track Ipca Laboratories Share Price on Univest for live updates, valuation ratios, shareholding pattern, 52-week levels and market insights. Univest keeps these details together for easy reference. The previous close was Rs 1,996.65.
